News & Updates

Bariatric surgery provides cardioprotection in patients with severe obesity, NAFLD
Bariatric surgery provides cardioprotection in patients with severe obesity, NAFLD
09 Nov 2022

Patients with severe obesity and nonalcoholic fatty liver disease (NAFLD) appear to benefit from bariatric surgery, which significantly reduces the risk of cardiovascular disease (CVD), a study has found.

Bariatric surgery provides cardioprotection in patients with severe obesity, NAFLD
09 Nov 2022
Alcohol-related liver disease poses increased risk of cardiovascular disease
Alcohol-related liver disease poses increased risk of cardiovascular disease
07 Nov 2022

Patients with biopsy-proven alcohol-related liver disease (ALD) appear to have a higher frequency of cardiovascular disease (CVD) than their counterparts without ALD, according to a study. The increased rates are especially pronounced just after ALD diagnosis.

Alcohol-related liver disease poses increased risk of cardiovascular disease
07 Nov 2022
Donor hypertension worsens graft survival, function in kidney recipients
Donor hypertension worsens graft survival, function in kidney recipients
06 Nov 2022

Kidney transplant recipients from living donors with hypertension are at significantly increased risk of renal allograft loss compared to those from normotensive living donors, reveals a study. Moreover, outcomes are similar to recipients of normotensive deceased donors.

Donor hypertension worsens graft survival, function in kidney recipients
06 Nov 2022
Statin use linked to reduced risk of severe COVID-19 outcomes
Statin use linked to reduced risk of severe COVID-19 outcomes
06 Nov 2022 byRoshini Claire Anthony

Patients who are on long-term statin therapy may have a reduced risk of severe COVID-19–related outcomes including mortality, intensive care unit (ICU) admission, and requirement for mechanical ventilation, according to a study presented at Anesthesiology 2022.

Statin use linked to reduced risk of severe COVID-19 outcomes
06 Nov 2022